Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $3.77 Million - $7.42 Million
59,300 Added 43.19%
196,600 $13.1 Billion
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $829,922 - $1.37 Million
8,200 Added 6.35%
137,300 $16.3 Billion
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $1.82 Million - $2.46 Million
21,300 Added 19.76%
129,100 $13.8 Billion
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $7.49 Million - $11.3 Million
107,800 New
107,800 $10.7 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Crawford Fund Management, LLC Portfolio

Follow Crawford Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Fund Management, LLC with notifications on news.